U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804563) titled 'Recreational Football for Young-to-middle-aged Inactive Men' on Aug. 31. Brief Summary: Th... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 ... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804186) titled 'Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic U... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Clinical and Economic Outcomes of Adding Semaglutide to Standard of Care in Adult P... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Int... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Platelet-Rich Plasma with Hyaluronic Acid Injections for Post- Viral Olfactory loss. A double-blin... Read More
U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804030) titled 'AI-Assisted Patient Support in mHSPC' on Sept. 01. Brief Summary: The purpose of this mult... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More
Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Leveraging AS01-induced immune cell reprogramming to modulate immune dysregulation in rheumatoid a... Read More